Amarin Corp Plc (AMRN)

[Whalatane]

Ralphey. thx ...my wife has the same problem getting insurers to cover some of the CKD scripts she writes ....so I understand your frustration .

From the business side ( ie insurers position ) ...AMRN is charging to much for Vascepa .
WAC ( wholesale acquisition cost ) I recall is around $120 per mth supply and Amarin's margins are around 80% ?....HDG has the exact figures so will defer to him on those.

The Canadian health system has already determined Vascepa is about 40% over priced ....as per Pharamdudes posts .

So AMRN has an option similar to what Gilead did with their Hep C drug

https://www.modernhealthcare.com/article/20180924/NEWS/180929949/gilead-to-launch-generic-versions-of-hepatitis-c-drugs.

AMRN wants to make $ for mgt and its share holders ...insurers want to save $ for their mgt and shareholders ....you MD's are caught in the middle just wanting the best for your patients.

IMHO insurers are playing the long game ...waiting to see if a GV is launched ...or if AMRN is willing to lower their WAC in exchange for easier coverage

Good luck
Kiwi